Collegium Pharmaceutical, Inc. (COLL)
After hours:
| Previous Close | 17.54 |
| Open | 17.43 |
| Bid | 6.00 x 900 |
| Ask | 20.65 x 1100 |
| Day's Range | 17.34 - 18.23 |
| 52 Week Range | 17.22 - 26.91 |
| Volume | |
| Avg. Volume | 286,249 |
| Market Cap | 612.212M |
| Beta (5Y Monthly) | 0.97 |
| PE Ratio (TTM) | 6.58 |
| EPS (TTM) | 2.69 |
| Earnings Date | Feb. 23, 2022 - Feb. 28, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25.00 |
- Simply Wall St.
Improved Earnings Required Before Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Find Their Feet
Collegium Pharmaceutical, Inc.'s ( NASDAQ:COLL ) price-to-earnings (or "P/E") ratio of 6.4x might make it look like a...
- GlobeNewswire
Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation
STOUGHTON, Mass., Dec. 28, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced the execution of a settlement framework to resolve all 27 pending opioid-related lawsuits brought against the Company by cities, counties, and other subdivisions in the United States. The settlement framework provides for the Company to pay an amount not to exceed $2,750,000 in exchange
- GlobeNewswire
Collegium Ranks as a Top Place to Work for 2021 by The Boston Globe
STOUGHTON, Mass., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has been named one of the Top Places to Work in Massachusetts in The Boston Globe’s 14th annual employee-based survey. Top Places to Work recognizes the most admired workplaces in the state voted on by the people who know them best—their employees. The survey measures employee op
